- Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implicationsWilliam D Graf
Departments of Pediatrics and Neurology, Yale University, New Haven, CT, USA
Neurology 80:1251-60. 2013..In nearly autonomous adolescents, the fiduciary obligation of the physician may be weaker, but the prescription of neuroenhancements is inadvisable because of numerous social, developmental, and professional integrity issues...
- Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional deficiencies, and maternal illnessWilliam D Graf
Departments of Pediatrics and Neurology, Yale University, New Haven, CT, USA Electronic address
Handb Clin Neurol 111:143-59. 2013..We provide a brief overview of clinical and experimental observations that link prenatal-onset toxic exposures, metabolic disturbances, and maternal illnesses to certain neurodevelopmental disorders...
- Addressing the problem of ADHD medication as neuroenhancementsWilliam D Graf
Departments of Pediatrics and Neurology, Yale University, PO Box 208064, 333 Cedar Street, New Haven, CT 06510, USA
Expert Rev Neurother 14:569-81. 2014..We argue against the 'spectrumization' of ADHD in an effort to curtail further diagnosis creep. ..